Ovarian cancer future or investigational therapies
Ovarian cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian cancer future or investigational therapies On the Web |
American Roentgen Ray Society Images of Ovarian cancer future or investigational therapies |
Ovarian cancer future or investigational therapies in the news |
Risk calculators and risk factors for Ovarian cancer future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Overview
Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future. Examples of the mechanism of action of these promising drugs are, targeting the angiogenesis, targeting (inhibit) DNA repair, targeting cell cycle, targeting signaling pathways, immunotherapeutic medications.
Investigational therapies
- Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future
- Examples of the mechanism of action of these promising drugs are:
- Targeting the angiogenesis
- Targeting (inhibit) DNA repair
- Targeting cell cycle
- Targeting signaling pathways
- Immunotherapeutic medications